Staska Pharma Recalls Ascorbic Acid Solution For Injection

LIKE.TG 成立于2020年,总部位于马来西亚,是首家汇集全球互联网产品,提供一站式软件产品解决方案的综合性品牌。唯一官方网站:www.like.tg
(RTTNews) - Staska Pharmaceuticals, Inc. is recalling one lot of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL, 50mL vials to the user level, according to the U.S. Food and Drug Administration. The recall was due to the presence of glass particulates in one lot of vials used in the production of the impacted batch.
The Ascorbic Acid Solution for Injection is used as a vitamin supplement and is packaged in amber colored vials and the affected lot is SP2400058 with an expiration date of 12/31/2024.
The impacted product was distributed across the country to licensed healthcare providers between 07/31/2024 and 08/27/2024.
According to the agency, administration of an injectable product that contains particulate matter may result in serious adverse events, including inflammation of a vein, granuloma, and blockage of blood vessels in the heart, lungs or brain which can cause stroke or life-threatening blood clot events, and even lead to death.
However, Staska has not received any reports of the presence of particulate matter, nor any adverse events related to the recall so far. The product label also contains a clear statement directing the healthcare professional to visually inspect the product for foreign particulate matter or precipitate before administering.
Staska has directly notified all customers who received the product and has arranged for the return and replacement of all recalled products.
In similar recalls, Sagent Pharmaceuticals in May called back two lots of chemotherapy drug Docetaxel Injection, USP due to potential presence of particulate matter from the stopper in the drug.
For More Such Health News, visit rttnews.com

现在关注【LIKE.TG出海指南频道】、【LIKE.TG大客户服务频道】,即可免费领取【WhatsApp、LINE、Telegram、Twitter、ZALO云控】等获客工具试用、【住宅IP、号段筛选】等免费资源,机会难得,快来解锁更多资源,助力您的业务飞速成长!点击【联系客服】
本文由LIKE.TG编辑部转载自互联网并编辑,如有侵权影响,请联系官方客服,将为您妥善处理。
This article is republished from public internet and edited by the LIKE.TG editorial department. If there is any infringement, please contact our official customer service for proper handling.
Server deployment全球论坛人工智能论坛全球峰会发展论坛战略论坛开放论坛程序员论坛互联网峰会科技峰会